Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hunan Eneng Biopharmaceutical

Request full access

Traditional Chinese Medicine (TCM) CXO and R&D services

ChinaFounded 2009

About Hunan Eneng Biopharmaceutical

Hunan Eneng Biopharmaceutical Co., Ltd., also known as Yi Neng Pharmaceutical, is a contract research organization (CRO) focused on Traditional Chinese Medicine (TCM). Founded in December 2009 by Dr. Yi Yueneng, the company provides end-to-end services for the development of new TCM and natural drugs. Dr. Yi holds a master's degree in Pharmaceutics and a Ph.D. in Pharmaceutical Analysis from Central South University and completed post-doctoral work at Fudan University.

Operating as a CXO (Contract Everything Organization), the firm offers a one-stop platform that encompasses research and development, clinical trials, and production technology empowerment for pharmaceutical companies globally. Its services cover the entire lifecycle of a drug, including pharmaceutical research, clinical study services from Phase II to IV, and post-launch research such as quality standard improvements and drug vigilance. The company has a particular focus on the development of classic TCM formulas, innovative TCM drugs, and hospital preparations. As of early 2023, the firm had worked on 83 classic prescriptions, 22 innovative TCM drugs, and successfully registered 56 hospital preparations.

The business model is based on providing specialized outsourced R&D and technical services to pharmaceutical companies and medical institutions, positioning it as a key support enterprise in the TCM industry. In March 2023, the company announced the completion of a Series A financing round of over 100 million yuan, led by the Guangdong Traditional Chinese Medicine Grand Health Fund, with participation from Whige Capital. This funding was intended to enhance its R&D capabilities and construct a smart Chinese medicine research and development base.

Source: Dealroom company data

At a glance

Status
Operational
Employees
3
Open positions
1
Dealroom signal
19.3/100

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Mar 2023 $14M $55M Hygeia Capital · Guangdong Traditional Chinese Medicine Health Fund ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Hunan Eneng Biopharmaceutical website traffic

Latest recorded traffic for Hunan Eneng Biopharmaceutical is 150 monthly website visits, down 51.6% over the last three months. Hunan Eneng Biopharmaceutical's team grew 0% over the past year.

Latest monthly visits150 3-month web change-51.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hunan Eneng Biopharmaceutical in its local ecosystem

Live from Dealroom

The Hunan Eneng Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Hygeia Capital
  • Guangdong Traditional Chinese Medicine Health Fund
Employees 3 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hunan Eneng Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hunan Eneng Biopharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.